Andrew Silver reports a stock award at CRISPR Therapeutics
By AlphaYouPublished Form 4
Silver Andrew Jacob
Reporting filer
Andrew Jacob Silver reports a stock award, not an open-market purchase or sale, in CRISPR Therapeutics AG. Form 4 filed Oct 28, 2026 lists 2 entries.
- Disclosed
- Oct 28, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Silver Andrew Jacob | 2026-10-26 | A | Grant or award | 18000 | 0 | 18,000 | 2 days | Filed terms
|
| Restricted Stock Units (derivative) | Silver Andrew Jacob | 2026-10-26 | A | Grant or award | 9000 | 0 | 9,000 | 2 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Silver Andrew Jacob
- Date
- 2026-10-26
- Code
- A
- Action
- Grant or award
- Quantity
- 18000
- Price
- 0
- Following holdings
- 18,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 49.01
- transaction Date: 2026-10-26
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 18000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-26
- underlying Security Title: Common Shares
- underlying Security Shares: 18000
- shares Owned Following Transaction: 18000
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Silver Andrew Jacob
- Date
- 2026-10-26
- Code
- A
- Action
- Grant or award
- Quantity
- 9000
- Price
- 0
- Following holdings
- 9,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F2
- transaction Date: 2026-10-26
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 9000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- id: F3
- underlying Security Title: Common Shares
- underlying Security Shares: 9000
- shares Owned Following Transaction: 9000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Silver Andrew Jacob: Chief Financial Officer.
- F1: This option was granted on October 26, 2026 with respect to 18,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 26, 2026.
- F2: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- F3: This restricted stock unit award was granted on October 26, 2026 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on October 26, 2027, (ii) one quarter of the shares vesting on October 26, 2028, (iii) one quarter of the shares vesting on October 26, 2029, and (iv) one quarter of the shares vesting on October 26, 2030.
Original sources
Prepared automatically from public filing data. Report a correction.